Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PI3Kδ inhibitors(Phosphatidylinositol 3 kinase delta inhibitors), Syk inhibitors(Spleen tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25N7O4S |
InChIKeyRQLSUYHNKIYTFI-UHFFFAOYSA-N |
CAS Registry1648797-46-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 2 | - | - | |
Diffuse Large B-Cell Lymphoma | Phase 2 | - | - | |
Mantle-Cell Lymphoma | Phase 2 | - | - |